Published in
American Chemical Society, ACS Medicinal Chemistry Letters, 1(8), p. 133-137, 2016
DOI: 10.1021/acsmedchemlett.6b00471
Links
Tools
Development of 4-Heteroarylamino-1′-azaspiro[oxazole-5,3′-bicyclo[2.2.2]octanes] as α7 Nicotinic Receptor Agonists
Journal article published in 2016 by
Matthew D. Hill 
,
Haiquan Fang,
H. Dalton King,
Christiana I. Iwuagwu,
Ivar M. McDonald ,
James Cook ,
F. Christopher Zusi,
Robert A. Mate,
Ronald J. Knox,
Debra Post-Munson,
Amy Easton,
Regina Miller,
Kimberley Lentz,
Wendy Clarke,
Yulia Benitex
and other authors.
,
Haiquan Fang,
H. Dalton King,
Christiana I. Iwuagwu,
Ivar M. McDonald ,
James Cook ,
F. Christopher Zusi,
Robert A. Mate,
Ronald J. Knox,
Debra Post-Munson,
Amy Easton,
Regina Miller,
Kimberley Lentz,
Wendy Clarke,
Yulia Benitex
and other authors.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
Full text: Unavailable
Preprint: archiving allowed
- Must obtain written permission from Editor
- Must not violate ACS ethical Guidelines
Postprint:
archiving restricted
- Must obtain written permission from Editor
- Must not violate ACS ethical Guidelines
Published version:
archiving forbidden
Data provided by 